Health Technology · Medical Specialties · NSE: NURECA · data 2026-10-09

Nureca Ltd.

Health check: Average (5.2/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹331.65

Market cap

₹316 cr

P/E

79.1

P/B

—

ROE

1.1%

ROCE

3.4%

Debt / equity

0.01

Dividend yield

0.00%

1-year return

42.8%

52-week high

₹376

52-week low

₹204

Operating margin

6.8%

Growth

Revenue (last 12 months)	₹153 cr
Net profit (last 12 months)	₹4 cr
Sales growth, 3 years (yearly)	9.7%
Profit growth, 3 years (yearly)	—

Similar companies

Q-Line Biotech Limited (QLINE) · MIC Electronics Limited (MICEL) · Osel Devices Limited (OSELDEVICE) · Yash Optics and Lens Limited (YASHOPTICS) · Avience Biomedicals Limited (AVIENCE)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open NURECA in NSE Scanner →